John G Ullman & Associates Inc. Trims Stock Position in Avantor, Inc. $AVTR

John G Ullman & Associates Inc. trimmed its holdings in Avantor, Inc. (NYSE:AVTR) by 91.7% in the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 11,400 shares of the company’s stock after selling 126,449 shares during the period. John G Ullman & Associates Inc.’s holdings in Avantor were worth $153,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Signaturefd LLC lifted its stake in shares of Avantor by 19.8% in the 1st quarter. Signaturefd LLC now owns 5,470 shares of the company’s stock valued at $89,000 after purchasing an additional 904 shares during the last quarter. Truist Financial Corp raised its holdings in Avantor by 2.2% in the 2nd quarter. Truist Financial Corp now owns 44,325 shares of the company’s stock valued at $597,000 after buying an additional 959 shares during the period. Xponance Inc. lifted its position in Avantor by 0.9% in the first quarter. Xponance Inc. now owns 114,422 shares of the company’s stock valued at $1,855,000 after buying an additional 966 shares during the last quarter. Louisiana State Employees Retirement System lifted its position in Avantor by 0.5% in the second quarter. Louisiana State Employees Retirement System now owns 191,700 shares of the company’s stock valued at $2,580,000 after buying an additional 1,000 shares during the last quarter. Finally, Nissay Asset Management Corp Japan ADV boosted its stake in Avantor by 1.4% during the first quarter. Nissay Asset Management Corp Japan ADV now owns 83,661 shares of the company’s stock worth $1,356,000 after buying an additional 1,138 shares during the period. Institutional investors and hedge funds own 95.08% of the company’s stock.

Avantor Stock Performance

NYSE:AVTR opened at $14.82 on Monday. Avantor, Inc. has a 52 week low of $10.82 and a 52 week high of $24.86. The company has a fifty day simple moving average of $13.07 and a two-hundred day simple moving average of $13.33. The company has a quick ratio of 0.67, a current ratio of 0.98 and a debt-to-equity ratio of 0.48. The company has a market cap of $10.10 billion, a price-to-earnings ratio of 14.97, a price-to-earnings-growth ratio of 4.83 and a beta of 0.98.

Avantor (NYSE:AVTR) last released its earnings results on Friday, August 1st. The company reported $0.24 EPS for the quarter, missing the consensus estimate of $0.25 by ($0.01). Avantor had a return on equity of 11.39% and a net margin of 10.31%.The company had revenue of $1.68 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same period in the previous year, the firm earned $0.25 earnings per share. The company’s revenue for the quarter was down 1.1% compared to the same quarter last year. As a group, equities analysts anticipate that Avantor, Inc. will post 1.06 earnings per share for the current fiscal year.

Insider Activity at Avantor

In related news, CAO Steven W. Eck sold 3,476 shares of the company’s stock in a transaction that occurred on Tuesday, August 5th. The shares were sold at an average price of $11.39, for a total transaction of $39,591.64. Following the sale, the chief accounting officer directly owned 55,068 shares in the company, valued at approximately $627,224.52. This represents a 5.94% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.20% of the company’s stock.

Analyst Ratings Changes

AVTR has been the topic of a number of research analyst reports. Wells Fargo & Company reduced their price target on shares of Avantor from $19.00 to $16.00 and set an “overweight” rating on the stock in a research note on Monday, August 4th. Jefferies Financial Group reissued a “hold” rating on shares of Avantor in a research report on Friday, August 1st. JPMorgan Chase & Co. decreased their price target on Avantor from $17.00 to $14.00 and set an “overweight” rating on the stock in a research note on Monday, August 4th. Raymond James Financial lifted their price objective on Avantor from $14.00 to $16.00 and gave the company an “outperform” rating in a research note on Thursday. Finally, Stifel Nicolaus set a $12.00 price objective on Avantor and gave the company a “hold” rating in a report on Monday, August 4th. Seven research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $15.81.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.